Article

Prognostic biomarkers for lung adenocarcinoma based on Mendelian randomization analysis

2024-03-29

Abstract excerpt

<h4>Background: </h4> Lung adenocarcinoma (LUAD) is a multifaceted disease with diverse locations and timing of gene mutations, histology, and molecular pathogenesis. As a result, identifying target genes for the treatment of patients with LUAD has become a major challenge. Method We downloaded the gene expression profiles of 220 patients with LUAD from the Gene Expression Omnibus (GEO) database and found the dif...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: faba8b25-a4f0-5e44-97df-3da3c1093840
DOI: 10.21203/rs.3.rs-4154926/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic biomarkers for lung adenocarcinoma based on Mendelian randomization analysisDOI 10.21203/rs.3.rs-4154926/v1Read

Prognostic biomarkers for lung adenocarcinoma based on Mendelian randomization analysis.Semantic proximity Read

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.Semantic proximity Read

Biomarkers Exploration of Epithelial-Mesenchymal Transition and Ferroptosis in Lung Adenocarcinoma: Transcriptomic Analysis and Mendelian RandomizationSemantic proximity Read

Systematic Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinomaSemantic proximity Read

A prognostic score model based on eight metabolism-associated genes predicts the survival of adult females with lung adenocarcinomaSemantic proximity Read

Inflammatory factors and risk of lung adenocarcinoma: a Mendelian randomization study mediated by blood metabolites.Semantic proximity Read

Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional charactersSemantic proximity Read

Novel molecular subtype-based precision therapy improves prognosis for lung adenocarcinoma patientsSemantic proximity Read

Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis.Semantic proximity Read

Integration and deconvolution methodology deciphering prognosis-related signatures in lung adenocarcinomaSemantic proximity Read

Bidirectional mendelian randomization and single-cell sequencing reveal T cell-mediated causal links between COPD and lung adenocarcinomaSemantic proximity Read

Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.Semantic proximity Read